Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging Read More > May 15, 2018
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Read More > May 15, 2018
Biocatalytic production of psilocybin and derivatives in tryptophan synthase-enhanced reactions Read More > May 11, 2018
Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users? Read More > May 7, 2018
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? Read More > May 3, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Read More > May 1, 2018
The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption Read More > April 30, 2018
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption Read More > April 30, 2018
